Vagal Nerve Stimulation in mTBI (VNS mTBI)
Primary Purpose
PTSD, mTBI
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
sham stimulation
nVNS
Sponsored by

About this trial
This is an interventional treatment trial for PTSD focused on measuring vagus nerve, stress disorders, posttraumatic, traumatic brain injury, memory, hippocampus, emission tomography
Eligibility Criteria
Inclusion Criteria:
- Veterans with mTBI and PTSD
Exclusion Criteria:
- amnesia for the inciting event lasted longer than 24 hours
- Glasgow Coma Scale Score after 30 minutes was less than 13
- loss of consciousness more than 30 minutes
- positive pregnancy test
- meningitis or other neurological disorder other than mTBI
- alcohol or substance abuse use disorder based on the SCID within the past 12 months
- current or lifetime history of schizophrenia, schizoaffective disorder, bipolar disorder, anorexia nervosa or bulimia, based on the SCID
- active suicidal ideation based on criteria outlined below
- a history of serious medical or neurological illness, such as cardiovascular, gastrointestinal, hepatic, renal, neurologic or other systemic illness
- active neuroleptic, opiate, or benzodiazepine treatment
- structural abnormality on brain MRI or CT
Sites / Locations
- Atlanta VA Medical and Rehab Center, Decatur, GARecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Sham Comparator
Arm Label
nVNS
sham
Arm Description
non invasive vagal nerve stimulation
sham stimulation
Outcomes
Primary Outcome Measures
CAPS
The Clinician Administered Posttraumatic Stress Disorder (PTSD) Scale (CAPS) is a measure of PTSD symptoms with a range of 0-80 and higher score indicating more severe PTSD symptoms. We will compare change from baseline to post treatment with active vagal nerve stimulation (VNS) or sham stimulation twice daily.
insula
Blood flow in the insula is measured with positron emission tomography (PET) and radiolabelled water during the performance of stress tasks. We compare blood flow in the insula to whole brain blood flow ratio during stress tasks (listening to personalized traumatic scripts) versus control tasks in the VNS versus sham groups with hypothesis of blocked insula blood flow with VNS
HVLT-R % retention
The Hopkins Verbal Learning Test-Revised (HVLT-R) is a test of declarative memory learning that involves the learning of 12 nouns, four from each of three semantic categories, learned over three learning trials, followed 20 minutes later by a delayed free recall trial and recognition trial composed of 24 words with 12 false positives. The percent (%) retention is calculated by dividing the delayed recall trial by the higher of learning trial 2 or 3. HLVT-R % retention has a range of 0-100 with 100 being best and 0 worst performance. Baseline and three months post treatment paired with sham or active stimulation are compared.
Change in IL6 Concentration in Blood with Stress
Interleukin-6 (IL6) response to stress paired with active or sham stimulation. IL6 is an inflammatory biomarker measured in blood. We compare IL6 response to stress in VNS versus sham treated groups.
hippocampal activation
Blood flow in the hippocampus is measured with positron emission tomography (PET) and radiolabelled water during the performance of declarative memory tasks. We compare blood flow in the hippocampus to whole brain blood flow ratio during memory tasks versus control tasks in the VNS versus sham groups with hypothesis of increased hippocampal blood flow with VNS
Secondary Outcome Measures
PPG amplitude
Photoplethysmography (PPG) amplitude is a measure of peripheral vasoconstriction which is a marker of sympathetic response to stress with active or sham. PPG amplitude is the diameter of the blood vessel in the finger, we measure change from baseline to post active vagal nerve stimulation versus sham stimulation with stress.
Full Information
NCT ID
NCT04437498
First Posted
May 29, 2020
Last Updated
May 17, 2023
Sponsor
VA Office of Research and Development
Collaborators
Atlanta VA Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT04437498
Brief Title
Vagal Nerve Stimulation in mTBI
Acronym
VNS mTBI
Official Title
Non-Invasive Vagal Nerve Stimulation in Veterans With Mild Traumatic Brain Injury (mTBI)
Study Type
Interventional
2. Study Status
Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
February 25, 2021 (Actual)
Primary Completion Date
September 20, 2025 (Anticipated)
Study Completion Date
January 15, 2026 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development
Collaborators
Atlanta VA Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Mild traumatic brain injury (mTBI) and posttraumatic stress disorder (PTSD) are important conditions for the Veterans Administration (VA) that frequently occur together in combat Veterans from the conflicts in Afghanistan and Iraq. In many Veterans these become chronic, raising the risk the burden of neurotrauma can worsen over time. This study will examine a new intervention called non-invasive Vagal Nerve Stimulation (nVNS) and its effects on memory and symptoms of PTSD and mTBI as well as brain and physiology in Veterans with mTBI and PTSD.
Detailed Description
This projects will assess the effects of non-invasive Vagal Nerve Stimulation (nVNS) on neurobiology and cognition in combat Veterans with mild Traumatic Brain Injury (mTBI) and co-morbid posttraumatic stress disorder (PTSD) during the performance of stressful tasks (traumatic scripts, mental arithmetic) and verbal declarative memory tasks using measurement of memory performance, peripheral inflammatory markers in blood (IL6) and cardiovascular responses using wearable gated sensing devices and electro- and seismocardiography, as well as brain response (anterior cingulate, hippocampus) measured with High Resolution Positron Emission Tomography (HR-PET) and radiolabelled water (15O[H2O]). The investigators hypothesize that nVNS but not sham control will result in enhanced memory, and hippocampal activation with memory encoding, and reduced cardiovascular, sympathetic, and inflammatory responses to stress. The investigators will also assess the effects of nVNS and sham on memory retention when applied to the encoding phase of a declarative memory learning task repeated daily over a four day period and on ratings of PTSD and pain in Veterans with mTBI and co-morbid PTSD and repeat assessments after three months of twice daily treatments.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
PTSD, mTBI
Keywords
vagus nerve, stress disorders, posttraumatic, traumatic brain injury, memory, hippocampus, emission tomography
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Veterans are randomized to double blind treatment with active non-invasive Vagal Nerve Stimulation (nVNS) or a sham control.
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Masking Description
code for active and sham devices kept by non study personnel.
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
nVNS
Arm Type
Experimental
Arm Description
non invasive vagal nerve stimulation
Arm Title
sham
Arm Type
Sham Comparator
Arm Description
sham stimulation
Intervention Type
Device
Intervention Name(s)
sham stimulation
Intervention Description
non invasive vagal nerve stimulation
Intervention Type
Device
Intervention Name(s)
nVNS
Intervention Description
active vns stimulation
Primary Outcome Measure Information:
Title
CAPS
Description
The Clinician Administered Posttraumatic Stress Disorder (PTSD) Scale (CAPS) is a measure of PTSD symptoms with a range of 0-80 and higher score indicating more severe PTSD symptoms. We will compare change from baseline to post treatment with active vagal nerve stimulation (VNS) or sham stimulation twice daily.
Time Frame
three months
Title
insula
Description
Blood flow in the insula is measured with positron emission tomography (PET) and radiolabelled water during the performance of stress tasks. We compare blood flow in the insula to whole brain blood flow ratio during stress tasks (listening to personalized traumatic scripts) versus control tasks in the VNS versus sham groups with hypothesis of blocked insula blood flow with VNS
Time Frame
10 minutes
Title
HVLT-R % retention
Description
The Hopkins Verbal Learning Test-Revised (HVLT-R) is a test of declarative memory learning that involves the learning of 12 nouns, four from each of three semantic categories, learned over three learning trials, followed 20 minutes later by a delayed free recall trial and recognition trial composed of 24 words with 12 false positives. The percent (%) retention is calculated by dividing the delayed recall trial by the higher of learning trial 2 or 3. HLVT-R % retention has a range of 0-100 with 100 being best and 0 worst performance. Baseline and three months post treatment paired with sham or active stimulation are compared.
Time Frame
baseline versus three months
Title
Change in IL6 Concentration in Blood with Stress
Description
Interleukin-6 (IL6) response to stress paired with active or sham stimulation. IL6 is an inflammatory biomarker measured in blood. We compare IL6 response to stress in VNS versus sham treated groups.
Time Frame
Baseline to 120 minutes after stress
Title
hippocampal activation
Description
Blood flow in the hippocampus is measured with positron emission tomography (PET) and radiolabelled water during the performance of declarative memory tasks. We compare blood flow in the hippocampus to whole brain blood flow ratio during memory tasks versus control tasks in the VNS versus sham groups with hypothesis of increased hippocampal blood flow with VNS
Time Frame
10 minutes
Secondary Outcome Measure Information:
Title
PPG amplitude
Description
Photoplethysmography (PPG) amplitude is a measure of peripheral vasoconstriction which is a marker of sympathetic response to stress with active or sham. PPG amplitude is the diameter of the blood vessel in the finger, we measure change from baseline to post active vagal nerve stimulation versus sham stimulation with stress.
Time Frame
Change from baseline to 5 seconds after the termination of stimulation paired with stress
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Veterans with mTBI and PTSD
Exclusion Criteria:
amnesia for the inciting event lasted longer than 24 hours
Glasgow Coma Scale Score after 30 minutes was less than 13
loss of consciousness more than 30 minutes
positive pregnancy test
meningitis or other neurological disorder other than mTBI
alcohol or substance abuse use disorder based on the SCID within the past 12 months
current or lifetime history of schizophrenia, schizoaffective disorder, bipolar disorder, anorexia nervosa or bulimia, based on the SCID
active suicidal ideation based on criteria outlined below
a history of serious medical or neurological illness, such as cardiovascular, gastrointestinal, hepatic, renal, neurologic or other systemic illness
active neuroleptic, opiate, or benzodiazepine treatment
structural abnormality on brain MRI or CT
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Doug J Bremner, MD
Phone
(404) 712-9569
Email
James.Bremner@va.gov
First Name & Middle Initial & Last Name or Official Title & Degree
Anna Woodbury, MD
Phone
(404) 321-6111
Ext
6939
Email
Anna.Woodbury@va.gov
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Doug J Bremner, MD
Organizational Affiliation
Atlanta VA Medical and Rehab Center, Decatur, GA
Official's Role
Principal Investigator
Facility Information:
Facility Name
Atlanta VA Medical and Rehab Center, Decatur, GA
City
Decatur
State/Province
Georgia
ZIP/Postal Code
30033-4004
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ashley N Scales
Phone
404-321-6111
Ext
23952
Email
Ashley.Scales@va.gov
First Name & Middle Initial & Last Name & Degree
Michael Hart, MD
Phone
(404) 321-6111
Ext
206170
Email
Michael.Hart3@va.gov
First Name & Middle Initial & Last Name & Degree
Doug J Bremner, MD
12. IPD Sharing Statement
Plan to Share IPD
Yes
IPD Sharing Time Frame
three months after study end
IPD Sharing Access Criteria
de identified data for three years
Learn more about this trial
Vagal Nerve Stimulation in mTBI
We'll reach out to this number within 24 hrs